Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reversal of cirrhosis: an achievable goal of hepatitis B antiviral therapy.

Literature DB >> 23673137

Reversal of cirrhosis: an achievable goal of hepatitis B antiviral therapy.

Yun-Fan Liaw¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2013 PMID： 23673137 DOI： 10.1016/j.jhep.2013.05.007

Source DB: PubMed Journal: J Hepatol ISSN： 0168-8278 Impact factor: 25.083

Keyword Cloud
Cited

× No keyword cloud information.

26 in total

1. Platelets' increase is associated with improvement of liver fibrosis in entecavir-treated chronic hepatitis B patients with significant liver fibrosis.

Authors: Lin Wang; Bingqiong Wang; Hong You; Xiaoning Wu; Jialing Zhou; Xiaojuan Ou; Jidong Jia
Journal: Hepatol Int Date: 2018-04-26 Impact factor: 6.047

2. Liver shape analysis using partial least squares regression-based statistical shape model: application for understanding and staging of liver fibrosis.

Authors: Mazen Soufi; Yoshito Otake; Masatoshi Hori; Kazuya Moriguchi; Yasuharu Imai; Yoshiyuki Sawai; Takashi Ota; Noriyuki Tomiyama; Yoshinobu Sato
Journal: Int J Comput Assist Radiol Surg Date: 2019-11-08 Impact factor: 2.924

Review 3. Resolution of organ fibrosis.

Authors: Joon-Il Jun; Lester F Lau
Journal: J Clin Invest Date: 2018-01-02 Impact factor: 14.808

Review 4. Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease.

Authors: Francesco Paolo Russo; Kryssia Rodríguez-Castro; Laura Scribano; Giorgia Gottardo; Veronica Vanin; Fabio Farinati
Journal: World J Hepatol Date: 2015-05-18

5. Serum Mac-2-binding protein (M2BPGi) as a marker of chronological liver fibrosis in biliary atresia patients with cirrhosis.

Authors: Takehisa Ueno; Tasuku Kodama; Yuki Noguchi; Motonari Nomura; Ryuta Saka; Yuichi Takama; Yuko Tazuke; Kazuhiko Bessho; Hiroomi Okuyama
Journal: Pediatr Surg Int Date: 2019-08-07 Impact factor: 1.827

6. Calpain 9 as a therapeutic target in TGFβ-induced mesenchymal transition and fibrosis.

Authors: David H Kim; James D Beckett; Varun Nagpal; Manuel A Seman-Senderos; Russell A Gould; Tyler J Creamer; Elena Gallo MacFarlane; Yichun Chen; Djahida Bedja; Jonathan T Butcher; Wayne Mitzner; Rosanne Rouf; Shoji Hata; Daniel S Warren; Harry C Dietz
Journal: Sci Transl Med Date: 2019-07-17 Impact factor: 17.956

Reversal of cirrhosis: an achievable goal of hepatitis B antiviral therapy.

1. Platelets' increase is associated with improvement of liver fibrosis in entecavir-treated chronic hepatitis B patients with significant liver fibrosis.

2. Liver shape analysis using partial least squares regression-based statistical shape model: application for understanding and staging of liver fibrosis.

Review 3. Resolution of organ fibrosis.

Review 4. Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease.

5. Serum Mac-2-binding protein (M2BPGi) as a marker of chronological liver fibrosis in biliary atresia patients with cirrhosis.

6. Calpain 9 as a therapeutic target in TGFβ-induced mesenchymal transition and fibrosis.

7. The antifibrotic effects of the novel compound gorse isoflavone alkaloid on chemical liver injury in rats.

Review 8. Perspectives on current controversial issues in the management of chronic HBV infection.

9. Viral DNA-Dependent Induction of Innate Immune Response to Hepatitis B Virus in Immortalized Mouse Hepatocytes.

Review 10. Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside.